These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 25352008

  • 1. Resveratrol attenuates intermittent hypoxia-induced insulin resistance in rats: involvement of Sirtuin 1 and the phosphatidylinositol-4,5-bisphosphate 3-kinase/AKT pathway.
    Wang Q, Sun X, Li X, Dong X, Li P, Zhao L.
    Mol Med Rep; 2015 Jan; 11(1):151-8. PubMed ID: 25352008
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of long non‑coding RNA expression profiles induced by resveratrol and metformin treatment for hepatic insulin resistance.
    Shu L, Hou X, Song G, Wang C, Ma H.
    Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34581420
    [Abstract] [Full Text] [Related]

  • 3. Insulin resistance is associated with tissue-specific regulation of HIF-1α and HIF-2α during mild chronic intermittent hypoxia.
    Sacramento JF, Ribeiro MJ, Rodrigues T, Guarino MP, Diogo LN, Seiça R, Monteiro EC, Matafome P, Conde SV.
    Respir Physiol Neurobiol; 2016 Jul; 228():30-8. PubMed ID: 26993367
    [Abstract] [Full Text] [Related]

  • 4. A novel formula Sang-Tong-Jian improves glycometabolism and ameliorates insulin resistance by activating PI3K/AKT pathway in type 2 diabetic KKAy mice.
    Kuai M, Li Y, Sun X, Ma Z, Lin C, Jing Y, Lu Y, Chen Q, Wu X, Kong X, Bian H.
    Biomed Pharmacother; 2016 Dec; 84():1585-1594. PubMed ID: 27829545
    [Abstract] [Full Text] [Related]

  • 5. Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway.
    Guan P, Sun ZM, Wang N, Zhou J, Luo LF, Zhao YS, Ji ES.
    Life Sci; 2019 Sep 15; 233():116748. PubMed ID: 31412263
    [Abstract] [Full Text] [Related]

  • 6. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats.
    Chi TC, Chen WP, Chi TL, Kuo TF, Lee SS, Cheng JT, Su MJ.
    Life Sci; 2007 Apr 10; 80(18):1713-20. PubMed ID: 17346750
    [Abstract] [Full Text] [Related]

  • 7. Down-regulation of the klf5-c-Myc interaction due to klf5 phosphorylation mediates resveratrol repressing the caveolin-1 transcription through the PI3K/PKD1/Akt pathway.
    Yang H, Chen Q, Sun F, Zhao N, Wen L, Li L, Ran G.
    PLoS One; 2017 Apr 10; 12(12):e0189156. PubMed ID: 29211809
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative effects of energy restriction and resveratrol intake on glycemic control improvement.
    Milton-Laskibar I, Aguirre L, Macarulla MT, Etxeberria U, Milagro FI, Martínez JA, Contreras J, Portillo MP.
    Biofactors; 2017 May 06; 43(3):371-378. PubMed ID: 28218490
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1.
    Graham RM, Hernandez F, Puerta N, De Angulo G, Webster KA, Vanni S.
    Exp Mol Med; 2016 Feb 19; 48(2):e210. PubMed ID: 26891914
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities.
    Liu Z, Jiang C, Zhang J, Liu B, Du Q.
    J Diabetes; 2016 May 19; 8(3):324-35. PubMed ID: 25850408
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Resveratrol inhibits proliferation and migration through SIRT1 mediated post‑translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells.
    Chai R, Fu H, Zheng Z, Liu T, Ji S, Li G.
    Mol Med Rep; 2017 Dec 19; 16(6):8037-8044. PubMed ID: 28983625
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.